Mutant p53 protein as a predictor of survival in endometrial carcinoma
- 30 April 1996
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (4) , 598-602
- https://doi.org/10.1016/0959-8049(95)00636-2
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- p53 Expression in Epithelial Ovarian Neoplasms: Relationship to Clinical and Pathological Parameters, Ki-67 Expression and Flow CytometryGynecologic Oncology, 1994
- Apoptosis. Its significance in cancer and cancer TherapyCancer, 1994
- Prognostic significance of p53 immunostaining in epithelial ovarian cancer.Journal of Clinical Oncology, 1994
- Preparation of cell nuclei from fresh tissues for high‐quality DNA flow cytometryCytometry, 1993
- Prognostic significance of p53 overexpression in gastric and colorectal carcinomaBritish Journal of Cancer, 1992
- Prognostic Significance of Proliferation in Endometrial AdenocarcinomasInternational Journal of Gynecological Pathology, 1991
- p53 expression in human breast cancer related to survival and prognostic factors: An immunohistochemical studyThe Journal of Pathology, 1991
- AnnouncementsGynecologic Oncology, 1989
- The Prognosis In Early Endometrial CarcinomaActa Obstetricia et Gynecologica Scandinavica, 1989
- Risk factors and recurrent patterns in Stage I endometrial cancerAmerican Journal of Obstetrics and Gynecology, 1985